ARWR
Price
$36.26
Change
-$0.28 (-0.77%)
Updated
Oct 8, 02:24 PM (EDT)
Capitalization
5.05B
54 days until earnings call
VTYX
Price
$3.84
Change
-$0.14 (-3.52%)
Updated
Oct 8, 12:54 PM (EDT)
Capitalization
283.81M
35 days until earnings call
Interact to see
Advertisement

ARWR vs VTYX

Header iconARWR vs VTYX Comparison
Open Charts ARWR vs VTYXBanner chart's image
Arrowhead Pharmaceuticals
Price$36.26
Change-$0.28 (-0.77%)
Volume$1.82K
Capitalization5.05B
Ventyx Biosciences
Price$3.84
Change-$0.14 (-3.52%)
Volume$3.1K
Capitalization283.81M
ARWR vs VTYX Comparison Chart in %
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. VTYX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a StrongBuy and VTYX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (ARWR: $36.54 vs. VTYX: $3.98)
Brand notoriety: ARWR: Notable vs. VTYX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 86% vs. VTYX: 179%
Market capitalization -- ARWR: $5.05B vs. VTYX: $283.81M
ARWR [@Biotechnology] is valued at $5.05B. VTYX’s [@Biotechnology] market capitalization is $283.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARWR and VTYX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 3 TA indicator(s) are bullish while VTYX’s TA Score has 5 bullish TA indicator(s).

  • ARWR’s TA Score: 3 bullish, 3 bearish.
  • VTYX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ARWR and VTYX are a good buy in the short-term.

Price Growth

ARWR (@Biotechnology) experienced а +5.94% price change this week, while VTYX (@Biotechnology) price change was +27.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.47%. For the same industry, the average monthly price growth was +19.41%, and the average quarterly price growth was +87.84%.

Reported Earning Dates

ARWR is expected to report earnings on Dec 01, 2025.

VTYX is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+9.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($5.05B) has a higher market cap than VTYX($284M). ARWR YTD gains are higher at: 94.362 vs. VTYX (81.735). ARWR has higher annual earnings (EBITDA): -52.51M vs. VTYX (-129.1M). ARWR has more cash in the bank: 900M vs. VTYX (209M). VTYX has less debt than ARWR: VTYX (10.3M) vs ARWR (353M). ARWR has higher revenues than VTYX: ARWR (573M) vs VTYX (0).
ARWRVTYXARWR / VTYX
Capitalization5.05B284M1,779%
EBITDA-52.51M-129.1M41%
Gain YTD94.36281.735115%
P/E RatioN/AN/A-
Revenue573M0-
Total Cash900M209M431%
Total Debt353M10.3M3,427%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRVTYX
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 9 days ago
73%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMRB4.910.01
+0.20%
First Commerce Bancorp Inc.
JYSKY19.15N/A
N/A
Jyske Bank A/S
MGLLF6.42N/A
N/A
Magellan Financial Group Ltd.
WLSS3.50N/A
N/A
WELSIS CORP.
IFNNF38.89-1.31
-3.26%
Infineon Technologies AG

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with KYMR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
+6.70%
KYMR - VTYX
47%
Loosely correlated
-1.09%
SYRE - VTYX
46%
Loosely correlated
-3.90%
ADCT - VTYX
44%
Loosely correlated
-2.71%
ARWR - VTYX
43%
Loosely correlated
-2.56%
IDYA - VTYX
42%
Loosely correlated
-2.07%
More